Death with Dignity Acts have gained national attention, as the result of a recent initiative by a 29-year-old terminally ill cancer patient.
For patients with less than a year to live, the discontinuation of statins may increase the median time-to-death and improve quality of life.
Ostensibly, the illness is the culprit. But it is also the cancer patient who is made culpable
Patients fear being a "guinea pig" or receiving a placebo, healthcare providers do not have time to keep up with all of the clinical trial information or talk with patients in depth, conducting clinical trials is very expensive for healthcare systems, and funding continues to decline for research.
Improving communication, building relationships, coordinating activities among units, and engaging staff members are not only ways to create a more positive working environment, they are critical for maintaining patient safety.
A growing proportion of cancer patients and cancer survivors are adopting CAM diets and taking herbs, vitamins, and supplements for their healing properties-not in place of standard cancer therapy, but along with it and beyond treatment.
Ann Partridge, MD, MPH, from Dana-Farber Cancer Institute and Sandy Truong, a Harvard Medical School student, discuss the needs of cancer survivors and their efforts to optimize survivorship care.
It is no surprise that increasing rates of obesity are linked to increasing cancer incidence, but what is interesting is just how bad things are now, and how bad they are predicted to become in the years ahead.
Rebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.
The security of genetic data collected from research study participants has emerged as a concern after investigators proved they could ferret out individual identities from large databases.